ZinMed is a biomedical science & technology company developing a non-invasive skin cancer screening system based on Raman spectroscopy and artificial intelligence, born from VNU's strong research group “AI in Healthcare”.
“Health within reach” — turning complex, invasive, expensive diagnostics into fast, painless, low-cost screening that Vietnam's grassroots healthcare can access.
ZinMed grew out of more than 10 years of research in spectroscopy and biomedical AI by scientists at UET, the International School and the University of Science (VNU).
In 2024, the team received VNU approval for a national-level project on skin cancer screening with Raman + AI (code QG.24.84). By 2025, the ZinRaman-D1 prototype and a 1,200-spectrum database were built, in collaboration with Samara University (Russia).
We are now entering multi-center clinical trials and completing medical-device documentation, heading toward a market-authorized product.
Every claim rests on data, publications and clinical validation.
AI assists, never replaces; clinical decisions always belong to the physician.
Prioritizing access for provincial and grassroots facilities in Vietnam.
Data security, full traceability, ISO 13485 and Decree 13/2023 compliance.
VNU approval · optical–electronic–mechanical design
≈500 clinical + 700 simulated · Samara University · 4-class AI + XAI
Target: multi-center sensitivity/specificity validation
Toward IEC 60825/60601 · multi-disease expansion
Bringing together experts in AI, biomedical electronics, physics and medicine from UET, International School and University of Science (VNU) with clinical specialists.
We are always looking for clinical partners, investors and research collaborators.
← Home